Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children

PHASE3CompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Growth Hormone DisorderPituitary Dwarfism
Interventions
DRUG

somatropin

Trial Locations (27)

10467

Novo Nordisk Investigational Site, The Bronx

11219

Novo Nordisk Investigational Site, Brooklyn

11570

Novo Nordisk Investigational Site, Rockville Centre

14222

Novo Nordisk Investigational Site, Buffalo

15213

Novo Nordisk Investigational Site, Pittsburgh

17033

Novo Nordisk Investigational Site, Hershey

19104

Novo Nordisk Investigational Site, Philadelphia

19107

Novo Nordisk Investigational Site, Philadelphia

29203

Novo Nordisk Investigational Site, Columbia

32308

Novo Nordisk Investigational Site, Tallahassee

33607

Novo Nordisk Investigational Site, Tampa

33701

Novo Nordisk Investigational Site, St. Petersburg

45229

Novo Nordisk Investigational Site, Cincinnati

49008

Novo Nordisk Investigational Site, Kalamazoo

55416

Novo Nordisk Investigational Site, Minneapolis

64108

Novo Nordisk Investigational Site, Kansas City

73104

Novo Nordisk Investigational Site, Oklahoma City

78284

Novo Nordisk Investigational Site, San Antonio

90027

Novo Nordisk Investigational Site, Los Angeles

92093

Novo Nordisk Investigational Site, San Diego

98105

Novo Nordisk Investigational Site, Seattle

94305-5208

Novo Nordisk Investigational Site, Stanford

46202-5225

Novo Nordisk Investigational Site, Indianapolis

02115

Novo Nordisk Investigational Site, Boston

01655

Novo Nordisk Investigational Site, Worcester

44308-1062

Novo Nordisk Investigational Site, Akron

53226-0509

Novo Nordisk Investigational Site, Milwaukee

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY